CAS-Envision

Shenzhen CAS-Envision Medical Technology Co., Ltd. was established in 2018, advocating and practicing the concept of "chip-level healthcare" and aiming to become a platform-type leading enterprise revolutionizing healthcare through cross-disciplinary chips. CAS-Envision has profound expertise in the field of biochips, aspiring to create a chip-level operating system that interconnects semiconductors and biotechnology, and to develop Class III high-end medical devices based on innovative cross-disciplinary semiconductor chips for high-sensitivity in vivo/in vitro sensing. These include ultra-high-resolution artificial electronic retinas, digital PCR/digital ELISA systems, and more. Additionally, the company has founded a subsidiary, Shenzhen Bowang Chuxin Semiconductor Technology, to provide diversified and advanced medical semiconductor chip solutions for niche sectors of high-end medical devices, filling the upstream gap in China’s medical chip industry.